Input interpretation
![aspirin](../image_source/f69c93a11d1e573514895c7dd75c0098.png)
aspirin
Chemical names and formulas
![formula | (CH_3CO_2)C_6H_4CO_2H Hill formula | C_9H_8O_4 name | aspirin IUPAC name | 2-acetyloxybenzoic acid alternate names | 2-(acetyloxy)benzoic acid | acenterine | acetosal | benzoic acid, 2-(acetyloxy)- mass fractions | C (carbon) 60% | H (hydrogen) 4.48% | O (oxygen) 35.5%](../image_source/47f2eeb7322675d9708cc47e889030fa.png)
formula | (CH_3CO_2)C_6H_4CO_2H Hill formula | C_9H_8O_4 name | aspirin IUPAC name | 2-acetyloxybenzoic acid alternate names | 2-(acetyloxy)benzoic acid | acenterine | acetosal | benzoic acid, 2-(acetyloxy)- mass fractions | C (carbon) 60% | H (hydrogen) 4.48% | O (oxygen) 35.5%
Lewis structure
![Draw the Lewis structure of aspirin. Start by drawing the overall structure of the molecule, ignoring potential double and triple bonds: Count the total valence electrons of the carbon (n_C, val = 4), hydrogen (n_H, val = 1), and oxygen (n_O, val = 6) atoms: 9 n_C, val + 8 n_H, val + 4 n_O, val = 68 Calculate the number of electrons needed to completely fill the valence shells for carbon (n_C, full = 8), hydrogen (n_H, full = 2), and oxygen (n_O, full = 8): 9 n_C, full + 8 n_H, full + 4 n_O, full = 120 Subtracting these two numbers shows that 120 - 68 = 52 bonding electrons are needed. Each bond has two electrons, so in addition to the 21 bonds already present in the diagram add 5 bonds. To minimize formal charge oxygen wants 2 bonds and carbon wants 4 bonds. Identify the atoms that want additional bonds and the number of electrons remaining on each atom: Fill in the 5 bonds by pairing electrons between adjacent highlighted atoms. Note that the six atom ring is aromatic, so that the single and double bonds may be rearranged: Answer: | |](../image_source/e422be5e80d6617d14307354e2da398d.png)
Draw the Lewis structure of aspirin. Start by drawing the overall structure of the molecule, ignoring potential double and triple bonds: Count the total valence electrons of the carbon (n_C, val = 4), hydrogen (n_H, val = 1), and oxygen (n_O, val = 6) atoms: 9 n_C, val + 8 n_H, val + 4 n_O, val = 68 Calculate the number of electrons needed to completely fill the valence shells for carbon (n_C, full = 8), hydrogen (n_H, full = 2), and oxygen (n_O, full = 8): 9 n_C, full + 8 n_H, full + 4 n_O, full = 120 Subtracting these two numbers shows that 120 - 68 = 52 bonding electrons are needed. Each bond has two electrons, so in addition to the 21 bonds already present in the diagram add 5 bonds. To minimize formal charge oxygen wants 2 bonds and carbon wants 4 bonds. Identify the atoms that want additional bonds and the number of electrons remaining on each atom: Fill in the 5 bonds by pairing electrons between adjacent highlighted atoms. Note that the six atom ring is aromatic, so that the single and double bonds may be rearranged: Answer: | |
3D structure
![3D structure](../image_source/42f5348f92557795443ead30ee1f506f.png)
3D structure
Basic properties
![molar mass | 180.16 g/mol phase | solid (at STP) melting point | 140 °C boiling point | 140 °C density | 1.39 g/cm^3](../image_source/e90cdf56290a8c450fd71c3f6c7bd8cb.png)
molar mass | 180.16 g/mol phase | solid (at STP) melting point | 140 °C boiling point | 140 °C density | 1.39 g/cm^3
Units
Hydrophobicity and permeability properties
![experimental LogP hydrophobicity | 1.4 predicted LogP hydrophobicity | 1.43 predicted LogS | -2.09 experimental Caco-2 permeability | -5.06](../image_source/fb141c4ba3bbb9f5d97c19a281a491f9.png)
experimental LogP hydrophobicity | 1.4 predicted LogP hydrophobicity | 1.43 predicted LogS | -2.09 experimental Caco-2 permeability | -5.06
Drug interactions
![acenocoumarol | acetazolamide | acetohexamide | anisindione | betamethasone | chlorpropamide | cortisone acetate | dexamethasone | dichlorphenamide | dicumarol | fludrocortisone | ginkgo biloba | glyburide | gliclazide | glipizide | glisoxepide | glycodiazine | griseofulvin | heparin | hydrocortisone | ... (total: 42)](../image_source/cbeed4439860f4ab69337e04f89661d2.png)
acenocoumarol | acetazolamide | acetohexamide | anisindione | betamethasone | chlorpropamide | cortisone acetate | dexamethasone | dichlorphenamide | dicumarol | fludrocortisone | ginkgo biloba | glyburide | gliclazide | glipizide | glisoxepide | glycodiazine | griseofulvin | heparin | hydrocortisone | ... (total: 42)
Basic drug properties
![approval status | approved | small molecule drug categories | non-steroidal anti-inflammatory agent | anticoagulant | cyclooxygenase inhibitor | fibrinolytic agent | platelet aggregation inhibitor | salicylate dosage forms | oral: gum | oral: liquid | oral: powder | oral: solution / drops | rectal: suppository | oral: tablet | oral: tablet, chewable | oral: tablet, coated | oral: tablet, delayed release](../image_source/390a39c51e4e88465550e9169cbe7cf5.png)
approval status | approved | small molecule drug categories | non-steroidal anti-inflammatory agent | anticoagulant | cyclooxygenase inhibitor | fibrinolytic agent | platelet aggregation inhibitor | salicylate dosage forms | oral: gum | oral: liquid | oral: powder | oral: solution / drops | rectal: suppository | oral: tablet | oral: tablet, chewable | oral: tablet, coated | oral: tablet, delayed release
![brand names | 8-hour bayer | A.S.A. empirin | acenterine | acesal | acetal | aceticyl | acetisal | acetol | acetonyl | acetophen | acetosal | acetosalin | acetylin | acetylsal | acimetten | acisal | acylpyrin | adiro | asagran | asatard | ascoden-30 | aspalon | aspec | aspergum | aspirdrops | aspirine | aspro | asteric | bayer extra strength aspirin for migraine pain | benaspir | Bi-prin | bialpirina | bialpirinia | bufferin | caprin | cemirit | claradin | clariprin | colfarit | contrheuma retard | coricidin | crystar | decaten | delgesic | dolean pH 8 | duramax | ECM | easprin | ecolen | ecotrin | empirin | endydol | entericin | enterophen | enterosarein | enterosarine | entrophen | extren | globentyl | globoid | helicon | idragin | levius | measurin | micristin | neuronika | novid | Nu-seals | Nu-seals aspirin | persistin | pharmacin | pirseal | polopiryna | premaspin | rheumintabletten | rhodine | rhonal | salacetin | salcetogen | saletin | solfrin | solprin | solprin acid | solpyron | spira-dine | St. joseph | St. joseph aspirin for adults | supac | tasprin | temperal | triaminicin | triple-sal | vanquish | xaxa | yasta](../image_source/4b3997c504e38de53336c0fc1fe13ea3.png)
brand names | 8-hour bayer | A.S.A. empirin | acenterine | acesal | acetal | aceticyl | acetisal | acetol | acetonyl | acetophen | acetosal | acetosalin | acetylin | acetylsal | acimetten | acisal | acylpyrin | adiro | asagran | asatard | ascoden-30 | aspalon | aspec | aspergum | aspirdrops | aspirine | aspro | asteric | bayer extra strength aspirin for migraine pain | benaspir | Bi-prin | bialpirina | bialpirinia | bufferin | caprin | cemirit | claradin | clariprin | colfarit | contrheuma retard | coricidin | crystar | decaten | delgesic | dolean pH 8 | duramax | ECM | easprin | ecolen | ecotrin | empirin | endydol | entericin | enterophen | enterosarein | enterosarine | entrophen | extren | globentyl | globoid | helicon | idragin | levius | measurin | micristin | neuronika | novid | Nu-seals | Nu-seals aspirin | persistin | pharmacin | pirseal | polopiryna | premaspin | rheumintabletten | rhodine | rhonal | salacetin | salcetogen | saletin | solfrin | solprin | solprin acid | solpyron | spira-dine | St. joseph | St. joseph aspirin for adults | supac | tasprin | temperal | triaminicin | triple-sal | vanquish | xaxa | yasta
Solid properties (at STP)
![density | 1.39 g/cm^3 vapor pressure | 3×10^-5 mmHg refractive index | 1.5623](../image_source/e17946bac178c402d6e04afda92399c6.png)
density | 1.39 g/cm^3 vapor pressure | 3×10^-5 mmHg refractive index | 1.5623
Units
Thermodynamic properties
![molar heat of vaporization | 106.4 kJ/mol specific heat of vaporization | 0.5906 kJ/g molar heat of combustion | 3927 kJ/mol specific heat of combustion | 21.8 kJ/g molar heat of fusion | 19.3 kJ/mol specific heat of fusion | 0.1071 kJ/g (at STP)](../image_source/9140bc13d12920eb563e10f439a1da21.png)
molar heat of vaporization | 106.4 kJ/mol specific heat of vaporization | 0.5906 kJ/g molar heat of combustion | 3927 kJ/mol specific heat of combustion | 21.8 kJ/g molar heat of fusion | 19.3 kJ/mol specific heat of fusion | 0.1071 kJ/g (at STP)
Chemical identifiers
![CAS number | 50-78-2 Beilstein number | 779271 PubChem CID number | 2244 PubChem SID number | 4594 SMILES identifier | CC(=O)OC1=CC=CC=C1C(=O)O InChI identifier | InChI=1/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H, 1H3, (H, 11, 12)/f/h11H InChI key | BSYNRYMUTXBXSQ-WXRBYKJCCW EU number | 200-064-1 RTECS number | VO0700000 NSC number | 406186](../image_source/8cd66ced4fe1ac2423ce3c3971f9f68d.png)
CAS number | 50-78-2 Beilstein number | 779271 PubChem CID number | 2244 PubChem SID number | 4594 SMILES identifier | CC(=O)OC1=CC=CC=C1C(=O)O InChI identifier | InChI=1/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H, 1H3, (H, 11, 12)/f/h11H InChI key | BSYNRYMUTXBXSQ-WXRBYKJCCW EU number | 200-064-1 RTECS number | VO0700000 NSC number | 406186
NFPA label
![NFPA label](../image_source/ad7cc79ff8aec0f8517baeb65e3e63f8.png)
NFPA label
![NFPA health rating | 2 NFPA fire rating | 1 NFPA reactivity rating | 0](../image_source/5d7f50050930afd9681f3d840055b83c.png)
NFPA health rating | 2 NFPA fire rating | 1 NFPA reactivity rating | 0
Safety properties
![flash point | 250 °C](../image_source/450911bb8a5d5d8487d9cecca3c3ce75.png)
flash point | 250 °C
![DOT hazard class | 6.1 DOT numbers | 2811](../image_source/8759c9d150cd4bc75c02c3c0b4e5a9a0.png)
DOT hazard class | 6.1 DOT numbers | 2811
Toxicity properties
![RTECS classes | drug | mutagen | reproductive effector | human data](../image_source/f942dc60e23a587fbb2991fa7b319ef3.png)
RTECS classes | drug | mutagen | reproductive effector | human data